Financials
- Market Capitalization 997.26 M
- Employee 21
- Founded 2012
- CEO N/A
- Website www.immixbio.com
- Headquarter Delaware, United States
- FIGI BBG00HLCWH09
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2451 | CADL Candel Therapeutics, Inc. - Common Stock | 13.06 USD | -5.02% | -0.53% | +33.13% | +123.25% | 999.33 M USD | ||
| 2452 | WVE Wave Life Sciences Ltd. - Ordinary Shares | 5.03 USD | -2.52% | -4.91% | -13.87% | -29.75% | 991.15 M USD | ||
| 2472 | GERN Geron Corporation - Common Stock | 1.51 USD | -1.31% | -0.66% | +4.86% | +4.86% | 970.13 M USD | ||
| 2485 | ANNX Annexon, Inc. - common stock | 4.96 USD | -5.52% | -2.17% | -0.20% | +133.96% | 940.31 M USD |
Frequently asked questions about Immix Biopharma, Inc. Common Stock
What is the Immix Biopharma, Inc. Common Stock stock price today?
The current price of Immix Biopharma, Inc. Common Stock (IMMX) is 13.94. Over the past 24 hours, the stock has changed by -2.59%. Follow the IMMX chart for real-time price dynamics.
What is the stock ticker of Immix Biopharma, Inc. Common Stock?
Immix Biopharma, Inc. Common Stock trades under the ticker IMMX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Immix Biopharma, Inc. Common Stock stock going up?
IMMX has changed by +2.05% over the last week, +64.58% over the last month, and +506.09% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Immix Biopharma, Inc. Common Stock?
Immix Biopharma, Inc. Common Stock currently has a market capitalization of 997.26 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Immix Biopharma, Inc. Common Stock earnings last quarter?
Last quarter, Immix Biopharma, Inc. Common Stock reported earnings of -0.18 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Immix Biopharma, Inc. Common Stock revenue for the last quarter?
Immix Biopharma, Inc. Common Stock reported quarterly revenue of 49.33 K. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Immix Biopharma, Inc. Common Stock net income for the last quarter?
Immix Biopharma, Inc. Common Stock reported net income of -11.56 M for the last quarter. The previous quarter showed -10.09 M, which means net income changed by -14.58%.
How many employees does Immix Biopharma, Inc. Common Stock have?
As of the latest available data, Immix Biopharma, Inc. Common Stock has 21 employees. Workforce size can provide additional context about the company's scale and operations.
What is Immix Biopharma, Inc. Common Stock EBITDA?
Immix Biopharma, Inc. Common Stock EBITDA is -12.28 M, and its EBITDA margin is -24.89 K%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Immix Biopharma, Inc. Common Stock stock?
You can buy Immix Biopharma, Inc. Common Stock (IMMX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Immix Biopharma, Inc. Common Stock stock?
Investing in Immix Biopharma, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the IMMX chart and related analysis on metatrader.com as part of your research.